Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 9—September 2005

Human Herpesvirus 8 and Pulmonary Hypertension

Emanuele Nicastri*Comments to Author , Carmine Dario Vizza†, Fabrizio Carletti*, Stefania Cicalini*, Roberto Badagliacca†, Roberto Poscia†, Giuseppe Ippolito*, Francesco Fedele†, and Nicola Petrosillo*
Author affiliations: *National Institute for Infectious Diseases IRCCS Lazzaro Spallanzani, Rome, Italy; †"La Sapienza" University, Rome, Italy

Main Article


Human herpesvirus 8 (HHV-8) seroprevalence among candidate patients for lung transplantation

Diagnosis Patients Female sex (%) Median age (range) HHV-8 seroprevalence (%)
Patients with pulmonary hypertension
Idiopathic pulmonary arterial hypertension 16 14 (87.5) 46 (28–74) 1 (6.3)
Secondary pulmonary hypertension 17 11 (64.7) 44 (22–65) 0 (0)
Patients without pulmonary hypertension
Cystic fibrosis 29 9 (31.0) 23 (14–28) 5 (17.2)
Interstitial lung disease 13 3 (23.1) 47 (43–74) 3 (23.1)

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.